Jacques P.H.M. Creemers

813 total citations
18 papers, 635 citations indexed

About

Jacques P.H.M. Creemers is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Radiological and Ultrasound Technology. According to data from OpenAlex, Jacques P.H.M. Creemers has authored 18 papers receiving a total of 635 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 14 papers in Physiology and 3 papers in Radiological and Ultrasound Technology. Recurrent topics in Jacques P.H.M. Creemers's work include Asthma and respiratory diseases (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Jacques P.H.M. Creemers is often cited by papers focused on Asthma and respiratory diseases (14 papers), Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers) and Inhalation and Respiratory Drug Delivery (7 papers). Jacques P.H.M. Creemers collaborates with scholars based in Netherlands, United Kingdom and France. Jacques P.H.M. Creemers's co-authors include David Price, Philip Fireman, Patti Stampone, Elizabeth F. Juniper, Vlastimil Vondra, Christian Brambilla, C.H. Compton, G. Schultze‐Werninghaus, A. W. Bakst and Ohad Amit and has published in prestigious journals such as The Lancet, CHEST Journal and Thorax.

In The Last Decade

Jacques P.H.M. Creemers

18 papers receiving 593 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jacques P.H.M. Creemers Netherlands 12 476 444 73 51 37 18 635
Eric Derom Belgium 13 343 0.7× 299 0.7× 23 0.3× 38 0.7× 36 1.0× 25 452
T. Clark United Kingdom 3 398 0.8× 482 1.1× 15 0.2× 34 0.7× 42 1.1× 5 587
Michael J. Asmus United States 12 182 0.4× 172 0.4× 13 0.2× 30 0.6× 26 0.7× 26 319
Cathy Jackson United Kingdom 9 141 0.3× 196 0.4× 15 0.2× 60 1.2× 26 0.7× 12 343
Eliana S. Mendes United States 11 287 0.6× 256 0.6× 37 0.5× 8 0.2× 13 0.4× 23 414
Sophie Demarche Belgium 12 228 0.5× 299 0.7× 41 0.6× 13 0.3× 10 0.3× 18 434
Claes‐Göran Löfdahl Sweden 11 415 0.9× 338 0.8× 27 0.4× 11 0.2× 16 0.4× 13 477
Vittorio Cardaci Italy 12 324 0.7× 121 0.3× 30 0.4× 17 0.3× 30 0.8× 28 464
Boudewijn J.H. Dierick Netherlands 7 141 0.3× 230 0.5× 13 0.2× 16 0.3× 26 0.7× 11 374
Amanda Howard-Thompson United States 9 72 0.2× 111 0.3× 23 0.3× 51 1.0× 12 0.3× 17 333

Countries citing papers authored by Jacques P.H.M. Creemers

Since Specialization
Citations

This map shows the geographic impact of Jacques P.H.M. Creemers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacques P.H.M. Creemers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacques P.H.M. Creemers more than expected).

Fields of papers citing papers by Jacques P.H.M. Creemers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacques P.H.M. Creemers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacques P.H.M. Creemers. The network helps show where Jacques P.H.M. Creemers may publish in the future.

Co-authorship network of co-authors of Jacques P.H.M. Creemers

This figure shows the co-authorship network connecting the top 25 collaborators of Jacques P.H.M. Creemers. A scholar is included among the top collaborators of Jacques P.H.M. Creemers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacques P.H.M. Creemers. Jacques P.H.M. Creemers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Houben, Carmen, Martijn A. Spruit, Hans Luyten, et al.. (2019). Cluster-randomised trial of a nurse-led advance care planning session in patients with COPD and their loved ones. Thorax. 74(4). 328–336. 55 indexed citations
2.
Janssen, Daisy J.A., et al.. (2019). Fentanyl nasal spray in a patient with end-stage COPD and severe chronic breathlessness. Breathe. 15(3). e122–e125. 4 indexed citations
3.
Houben, Carmen, Martijn A. Spruit, Hans Luyten, et al.. (2018). Late Breaking Abstract - A cluster-randomized trial of a nurse-led advance care planning session in patients with COPD and their loved ones. OA5194–OA5194. 2 indexed citations
4.
Houben, Carmen, Martijn A. Spruit, Emiel F.�M. Wouters, et al.. (2016). Preferences for end-of-life care in patients with COPD. PA1620–PA1620. 1 indexed citations
5.
Berge, Maarten van den, Wim C.J. Hop, Thys van der Molen, et al.. (2012). Prediction and course of symptoms and lung function around an exacerbation in chronic obstructive pulmonary disease. Respiratory Research. 13(1). 44–44. 30 indexed citations
6.
Vestbo, Jørgen, et al.. (2010). Onset of Effect of Aclidinium, a Novel, Long-Acting Muscarinic Antagonist, in Patients with COPD. COPD Journal of Chronic Obstructive Pulmonary Disease. 7(5). 331–336. 25 indexed citations
7.
Chanez, Pascal, Peter Burge, Rasmus Holmboe Dahl, et al.. (2009). Aclidinium bromide provides long-acting bronchodilation in patients with COPD. Pulmonary Pharmacology & Therapeutics. 23(1). 15–21. 41 indexed citations
8.
Wielders, Pascal, et al.. (2008). Efficacy of formoterol Turbuhaler in the emergency treatment of patients with obstructive airway diseases. Respiratory Medicine. 102(4). 579–585. 5 indexed citations
9.
Kuna, Piotr, Jacques P.H.M. Creemers, Vlastimil Vondra, et al.. (2006). Once-daily dosing with budesonide/formoterol compared with twice-daily budesonide/formoterol and once-daily budesonide in adults with mild to moderate asthma. Respiratory Medicine. 100(12). 2151–2159. 28 indexed citations
10.
Schermer, Tjard, et al.. (2004). Profiles of measured and perceived bronchodilation. A placebo-controlled cross-over trial comparing formoterol and salmeterol in moderate persistent asthma. Pulmonary Pharmacology & Therapeutics. 17(4). 205–212. 8 indexed citations
11.
12.
Buhl, Roland, et al.. (2003). Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma. Respiratory Medicine. 97(4). 323–330. 66 indexed citations
13.
14.
Kottakis, John, Giovanni Della Cioppa, Jacques P.H.M. Creemers, et al.. (2002). Faster Onset of Bronchodilation with Formoterol than with Salmeterol in Patients with Stable, Moderate‐Severe Copd: Results of a Randomized, Double‐Blind Clinical Study. Canadian Respiratory Journal. 9(2). 107–115. 42 indexed citations
15.
Dekhuijzen, P.N.R., et al.. (2002). An efficient and reproducible method for measuring hydrogen peroxide in exhaled breath condensate. Respiratory Medicine. 96(3). 197–203. 43 indexed citations
16.
Grouls, R. J. E., et al.. (2002). Pharmacodynamic effects of albuterol nebulization in hospitalized COPD‐patients because of an exacerbation with blocked gastrointestinal absorption. British Journal of Clinical Pharmacology. 53(5). 1 indexed citations
17.
Compton, C.H., Richard Nieman, Jeffrey D. Edelson, et al.. (2001). Cilomilast, a selective phosphodiesterase-4 inhibitor for treatment of patients with chronic obstructive pulmonary disease: a randomised, dose-ranging study. The Lancet. 358(9278). 265–270. 152 indexed citations
18.
Noord, J.A. van, et al.. (2000). Delivery of Fenoterol via Respimat<sup>®</sup>, a Novel ‘Soft Mist’ Inhaler. Respiration. 67(6). 672–678. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eric Derom Breakdown of academic impact, for papers by T. Clark Breakdown of academic impact, for papers by Michael J. Asmus Breakdown of academic impact, for papers by Cathy Jackson Breakdown of academic impact, for papers by Eliana S. Mendes Breakdown of academic impact, for papers by Sophie Demarche Breakdown of academic impact, for papers by Claes‐Göran Löfdahl Breakdown of academic impact, for papers by Vittorio Cardaci Breakdown of academic impact, for papers by Boudewijn J.H. Dierick Breakdown of academic impact, for papers by Amanda Howard-Thompson
Rankless by CCL
2026